Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Sponsors Invited To Trial Pre-Submission Meetings With South African Agency

Executive Summary

The South African Health Products Regulatory Authority is planning to introduce meetings with drug sponsors that can help identify and resolve potential shortcomings in marketing applications before they are submitted for evaluation.

You may also be interested in...



UK Regulator To Lose 20% Of Staff In Post-Brexit Cost-Cutting Plans

The MHRA intends to drop around 300 roles as it faces a financial crunch after leaving the EU and other pressures.

Global CRO Body Addresses Data Integrity In Decentralized Trials

The Association of Contract Research Organizations’ revised toolkit on decentralized trials explains how to deal with data quality and integrity. 

EMA Seeks To Clarify Similarity Assessment

The European Medicines Agency has updated its reflection paper on methodologies for comparative quality assessment. The paper clarifies expectations on the assessment of similarity for manufacturing changes and for generic and biosimilar development by introducing the concept of “similarity condition.”

Topics

UsernamePublicRestriction

Register

PS144639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel